Postmenopausal Vaginal Atrophy Clinical Trial
Official title:
Vaginal Estradiol Tablets (Vagifem®) and Endometrial Cancer Risk in the Treatment of Postmenopausal Vaginal Atrophy: A Register-based Cohort Study in Postmenopausal Women
The study will include data from a nationwide Danish cohort of postmenopausal women and the United States of America (US) cohort of postmenopausal women. The Danish nationwide cohort will be established through linkage of Danish national patient registries. The US cohort will be established based on data from US claims database, Truven. The aim of this study is to evaluate whether exposure to Vagifem® increases the rate of endometrial cancer in postmenopausal women.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01085877 -
Comparison of Two Vaginal Tablets, Produced at Different Sites, in Postmenopausal Women With Atrophic Vaginitis
|
Phase 1 | |
| Completed |
NCT00108849 -
Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms
|
Phase 3 | |
| Completed |
NCT00464971 -
Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Atrophic Vaginitis: An Extension Trial
|
Phase 3 | |
| Completed |
NCT00431132 -
Endometrial Safety of a Low Dose of Vagifem® in Postmenopausal Women With Atrophic Vaginitis
|
Phase 3 | |
| Completed |
NCT01486979 -
Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis
|
Phase 1 | |
| Completed |
NCT00465192 -
Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic Vaginitis
|
Phase 3 | |
| Completed |
NCT01507454 -
Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency
|
N/A |